broker commentary, page-17

TGA meeting is this Friday I think, so we should know either then or on Monday next week. EMA decision should follow a fortnight after.

I think part of the selling the last few weeks has been due to some employees cashing in part of their cheap option conversion shares in case of more regulatory delays.

However as the decision time gets closer its good to see some large buying demand coming back, as primaus points out.

Also agree with primaus that we should move somewhere between $3 & $4 on EMA approval and higher again on FDA approval next year.

Exciting times to be a PXS shareholder!